» Articles » PMID: 35937699

Vaginal Microecological Characteristics of Women in Different Physiological and Pathological Period

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

The vaginal microbiota, the host endocrine system, the vaginal anatomy, and the local mucosal immunity comprise the vaginal microbiota, which interacts with each other to maintain the balance of the vaginal microbiota, which maintains female reproductive health. Puberty, menstruation, pregnancy, and menopause are four phases women go through during their reproductive and post-reproductive years. Vaginal microbiota composition and abundance are heavily influenced by estrogen and progesterone, which start at puberty and continue during the reproductive years in a dynamic balance with some fluctuations. Estrogen promotes proliferation of vaginal epithelial cells and increases glycogen storage, while progesterone lyses vaginal epithelial cells, facilitating the release of glycogen to maintain normal pH. This review summarizes the latest national and international evidence on the composition and distribution of vaginal microecology in women during different physiological and pathological periods and proposes a hormone-driven microbial diversity hypothesis to explain the temporal patterns of vaginal microbial diversity during the female reproductive cycle and menopause. A relatively balanced vaginal microecological system has a positive effect on the maintenance of female health. An imbalance in the ratio of flora can lead to susceptibility to infections or reproductive complications. The study of human microecology and its role in the development and progression of human disease is essential for the prevention, diagnosis, and treatment of related obstetric and gynecologic conditions.

Citing Articles

Microbiome structure in healthy and pregnant women and importance of vaginal dysbiosis in spontaneous abortion.

Eslami M, Naderian R, Ahmadpour A, Shushtari A, Maleki S, Mohammadian P Front Cell Infect Microbiol. 2025; 14:1401610.

PMID: 40046910 PMC: 11881085. DOI: 10.3389/fcimb.2024.1401610.


Research progress on the interaction between intestinal flora and microRNA in pelvic inflammatory diseases.

Dong S, Du Y, Wang H, Yuan W, Ai W, Liu L Noncoding RNA Res. 2025; 11:303-312.

PMID: 39931541 PMC: 11808595. DOI: 10.1016/j.ncrna.2025.01.007.


Study on the efficacy of fractional CO laser treatment for vaginal relaxation syndrome combined with recurrent bacterial vaginitis.

Wang L, Chen L, Li Y, Song X, Mo J, Ding G Sci Rep. 2025; 15(1):1445.

PMID: 39789302 PMC: 11718247. DOI: 10.1038/s41598-025-85661-4.


Predictive value of CA-153, CA-125 and Apo A for ocular metastasis in menopausal female patients with breast cancer.

Liu Q, Ling Q, Zeng Y, Chen C, Wei H, Hu J Int J Ophthalmol. 2024; 17(12):2265-2275.

PMID: 39697887 PMC: 11589442. DOI: 10.18240/ijo.2024.12.15.


The Role of the Vaginal and Endometrial Microbiomes in Infertility and Their Impact on Pregnancy Outcomes in Light of Recent Literature.

Balla B, Illes A, Tobias B, Piko H, Beke A, Sipos M Int J Mol Sci. 2024; 25(23).

PMID: 39684937 PMC: 11642076. DOI: 10.3390/ijms252313227.


References
1.
Xu J, Bian G, Zheng M, Lu G, Chan W, Li W . Fertility factors affect the vaginal microbiome in women of reproductive age. Am J Reprod Immunol. 2020; 83(4):e13220. PMC: 7078941. DOI: 10.1111/aji.13220. View

2.
Sepich-Poore G, Zitvogel L, Straussman R, Hasty J, Wargo J, Knight R . The microbiome and human cancer. Science. 2021; 371(6536). PMC: 8767999. DOI: 10.1126/science.abc4552. View

3.
Zhou B, Sun C, Huang J, Xia M, Guo E, Li N . The biodiversity Composition of Microbiome in Ovarian Carcinoma Patients. Sci Rep. 2019; 9(1):1691. PMC: 6368644. DOI: 10.1038/s41598-018-38031-2. View

4.
Si J, You H, Yu J, Sung J, Ko G . Prevotella as a Hub for Vaginal Microbiota under the Influence of Host Genetics and Their Association with Obesity. Cell Host Microbe. 2016; 21(1):97-105. DOI: 10.1016/j.chom.2016.11.010. View

5.
Pickard J, Zeng M, Caruso R, Nunez G . Gut microbiota: Role in pathogen colonization, immune responses, and inflammatory disease. Immunol Rev. 2017; 279(1):70-89. PMC: 5657496. DOI: 10.1111/imr.12567. View